Cargando…
Effects of dexmedetomidine on subthalamic local field potentials in Parkinson's disease
BACKGROUND: Dexmedetomidine is frequently used for sedation during deep brain stimulator implantation in patients with Parkinson's disease, but its effect on subthalamic nucleus activity is not well known. The aim of this study was to quantify the effect of increasing doses of dexmedetomidine i...
Autores principales: | Martinez-Simon, Antonio, Valencia, Miguel, Cacho-Asenjo, Elena, Honorato-Cia, Cristina, Nuñez-Cordoba, Jorge M., Manzanilla, Oscar, Aldaz, Azucena, Panadero, Alfredo, Guridi, Jorge, Alegre, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362272/ https://www.ncbi.nlm.nih.gov/pubmed/33896591 http://dx.doi.org/10.1016/j.bja.2021.01.036 |
Ejemplares similares
-
COVID-19 publications in anaesthesiology journals: a bibliometric analysis
por: Martinez-Simon, Antonio, et al.
Publicado: (2022) -
Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s disease
por: Merk, Timon, et al.
Publicado: (2022) -
The aperiodic exponent of subthalamic field potentials reflects excitation/inhibition balance in Parkinsonism
por: Wiest, Christoph, et al.
Publicado: (2023) -
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis
por: Artusi, Carlo Alberto, et al.
Publicado: (2019) -
Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration
por: Aristieta, A., et al.
Publicado: (2013)